Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluenz immunogenicity and safety over three successive influenza seasons in children with or without prior Pandemrix exposure
2013-003592-35Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by UK Health Security Agency. Primary endpoints: Immunogenicity measures, Safety and 2 more. Started Dec 2013; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-003592-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003592-35.